U.S. ready to make bird flu vaccine

Even though officials in the United States say more testing needs to be done, the U.S. could begin mass production of an experimental avian flu vaccine by September.

In successful tests carried out on 450 healthy adults, results from 115 of those people have shown a high enough immune response to protect against the avian flu presently rife amongst birds in Asia and also now in Russia.

The head of the U.S. National Institute of Allergy and Infectious Diseases, Dr. Anthony S. Fauci, says he expects the other 335 patients to show a good response too.

Fauci says if the vaccine is effective, it will be a major step forward in preventing what many think will be the next pandemic flu.

However many experts feel that while the development is important, there is still a long way to go in deciding how much is put in each dose, how many doses are given, and how long it lasts for.

Researchers have already found that the current avian flu vaccine formulation requires a higher dose than seasonal flu vaccines, in order to trigger an immune response, and the elderly are likely to require even higher doses.

The government have apparently already ordered two million doses from a French manufacturer, but if testing indicates the formula should be changed that will not be possible.

According to Mike Leavitt, the U.S. Health and Human Services Secretary, the federal government wants to stockpile 20 million doses of the vaccine.

However pharmaceutical companies usually only make enough flu vaccine to cover the most vulnerable members of society, the elderly, children and the sick.

But it is thought that it might be possible for companies to make the seasonal flu vaccine and the bird flu vaccine at the same time.

The last pandemic, the Spanish Flu of 1918, killed 50 million people worldwide, and was in an era before air travel.

Many health experts have warned for months that if a pandemic evolves in Asia, it is only a matter of time before it ends up all over the world.

That the avian flu is already appearing in a number of countries, raises the level of concern.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Community partnerships lead to more inclusive health care for neurodiverse individuals